The CCSB has organized a leadership structure to provide expertise and fully support all initiatives. The leadership consists of the Principal Investigator, Chris Sander, PhD. Support personnel consists of the CCSB Research Director (TBN) and a staff assistant (TBN). The CCSB leadership and support personnel, also known as the Administration, will work collectively to support and accomplish the proposed research projects, core, educational and training unit, outreach and dissemination unit, and pilot and trans-network projects. The staff of the CCSB Administration will provide the organizational support and leadership to permit the research projects and core to accomplish their goals and to distribute the accomplishments of each CCSB lab among the CCSB investigators and around the world. Achieving this goal requires rapid and precise analysis of research data followed quickly by its dissemination to research team members and the scientific community. The CCSB Administration will work closely with CCSB investigators to achieve this latter objective. It will also provide budgetary review and scientific oversight. The CCSB Research Director, working with the Principal Investigator, will prepare and distribute a yearly progress report for the EAP to assist in their annual review and oversight. The CCSB Steering Committee will meet annually and will consist of one investigator from each CCSB. The Principal Investigator, Dr. Chris Sander, will represent our CCSB at the Steering Committee Meeting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA148967-04
Application #
8468149
Study Section
Special Emphasis Panel (ZCA1-SRLB-C)
Project Start
Project End
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
4
Fiscal Year
2013
Total Cost
$623,468
Indirect Cost
$256,367
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Argyropoulos, K V; Vogel, R; Ziegler, C et al. (2016) Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling. Leukemia 30:1116-25
Gao, Sizhi P; Chang, Qing; Mao, Ninghui et al. (2016) JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors. Sci Signal 9:ra33
Quail, Daniela F; Bowman, Robert L; Akkari, Leila et al. (2016) The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science 352:aad3018
Vogel, Robert M; Erez, Amir; Altan-Bonnet, Grégoire (2016) Dichotomy of cellular inhibition by small-molecule inhibitors revealed by single-cell analysis. Nat Commun 7:12428
Buffie, Charlie G; Bucci, Vanni; Stein, Richard R et al. (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205-8
Korkut, Anil; Wang, Weiqing; Demir, Emek et al. (2015) Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells. Elife 4:
Voisinne, Guillaume; Nixon, Briana G; Melbinger, Anna et al. (2015) T Cells Integrate Local and Global Cues to Discriminate between Structurally Similar Antigens. Cell Rep 11:1208-19
Klemm, Florian; Joyce, Johanna A (2015) Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 25:198-213
Prill, Robert J; Vogel, Robert; Cecchi, Guillermo A et al. (2015) Noise-driven causal inference in biomolecular networks. PLoS One 10:e0125777
Kaushik, Poorvi; Molinelli, Evan J; Miller, Martin L et al. (2014) Spatial normalization of reverse phase protein array data. PLoS One 9:e97213

Showing the most recent 10 out of 33 publications